Low dose of Pfizer-BioNTech vaccine is safe and effective in children ages 5 to 11, companies’ study finds
Monday, September 20, 2021 09:47 AM
A lower dose of the Pfizer-BioNTech coronavirus vaccine — one-third the amount given to adults and teens — is safe and triggered a robust immune response in children as young as 5 years old, the drug companies announced in a news release Monday morning. Read more.